Shenzhen Yilifang biotechnology Co., ltd.
Detection of genetic diseases, detection of infectious diseases of the respiratory tract, detection of tumor early or prognosis, detection of karyotype analysis

New products

Yilifang meters of biological long-term  ✘‌ focus on re technology research and development,₩Ω∏ promote the transformation of scientific and tλε₩echnological achievements with an op‍Ω≥₹en mind, and enhance t•φφhe ability of scientific and ✔≈αλtechnological value ™‌creation. Now it has a lar£ →ge number of high-quality technical←β professionals, inclu∑∏ding nearly 10 doctors and masters, witφ><h strong technical force and ↓β÷₩advanced development ability. In the f≥£✔™ace of long-term and sudden public hea↓®€lth problems, we continue to ↑☆✘<strive to develop all kinds of the latest and moλ∏εst comprehensive products.

Birth Defect Detection

China is a large populated country ♣∏with a high incidence of birth defects. Accorαβ←×ding to the "China Birth Defects Prevention≠‌ ☆ Report (2012)" released by the ₽σformer Ministry of Health in September 20↔σ12, the current incidence of birth defects in‌×& China is about 5.6%, and there≈₹÷ are about 900,000 new birth defects each ye♣"ar. Among them, there€ Ω€ are about 250,000 birth defects that are clλ☆↔♣inically visible at birth. "Ea∑×☆ rly detection, early prevention, eaβ£rly treatment" is the guiding principleβ  of the prevention and treatment of birth de≥&fects. The purpose of carrying out♥¥ genetic testing is t≠≤₽o prevent birth defects from t&↕he source. We launched a series">ε♠ of products in the context of the new era to a∏←πchieve: high science, high co​'≠↓verage, high suitability, high accu$ε×racy, high quality, and high cost-ef♦σ'♥fective.

Respiratory Infections

The detection of res£ ←™piratory pathogens is o↔$®ne of the main producti₽€‍on lines of Ecuador. The company was aware ‌£of the harmfulness and urg←¥  ency of the disease so>£δciety at the beginning of the company's &∏establishment, and organize£ ¥d several major technical brea<♦÷★kthroughs and double-chain fus§∞εion project declarations.&×<• After several years¥> of intensive cultivation, respiratory ‌∞±infection detection haφ"↕s formed a systematic product la♠&÷♥yout and established a core technolog€★≥$y platform. Currently, it has deve∏★<loped detection kits for more than 2©∑£0 common respiratory pathogens, and also develβ€oped POCT rapid detection and accurate Nu<φ✔cleic acid detection, multi-target detectΩ¥ion and single-target dete&♦"∑ction, better complement×≈$♠ each other, to achieve the best clinical≤<☆​ use and public health prevention and control.

Tumor Detection

Tumors are a genomic d→‍×♣isease. The occurrence of tumors begins with​≈★✘ genetic mutations, and genetic testingΩ∏≠ is the personalized treatment of tum≤  ors—a new era of prec♥₽♣☆ision medicine. Precision medicine is the l♥∑atest medical model developedπ≈'  on the basis of data from the H♦↕uman Genome Project and t ≈he results of evidence-based mediciΩ‍✔ne. Sex and effectiven& φ★ess, to avoid adverse reactions, is the >&most cutting-edge clinical practice model.

Cytogenetics (karyotyping)

The chromosome karyotype analysis is to analyz'≤€e the characteristics of chromosome length, ce‌↔♣←ntromere position, arm ratio, s£§©βatellite size, etc. in tΩ☆εhe cells of the organism. After the δ∏♠karyotype analysis, the cause of tαπ☆he organism can be judged based on the variation ¶₽σ±of the chromosome structure and number, s≤‍©uch as the disease caused by what kind of gen§₩π©e is missing. The major clinical★±Ω∑ly relevant diseases fo∑εr this test are: male Turner syndrome, men€π♣¶tal disorders associated with chromosoma' βl abnormalities, mixed ovari±☆an mixed germ cell-sexual inte↕αδrstitial tumors, congenital ovarian hy§₽poplasia in children,✘≠§​ and meow syndrome in​↔♥ children. Signs, pediatric androgen ins÷§ensitivity syndrome, pediatric androgeniδ€c deformity, pediatric Edwards syndro§≠≠me, myelodysplastic syndrome, myocl☆₽¥onic cerebellar coordination disorder and so∞π on.

Biochemical Reagents

Our company always a× ¶dheres to the goal of pro<α✔viding customers with suitable products. Under>☆× the premise of developing a ser↑€↑<ies of core technology diagnostic₽✔​ reagents, in order to cooperate with cus₽✔tomers to better work and enable cu÷♦™stomers to carry out work appropriately and e‍¥asily, we have also developed a series of $®​↕cost-effective and high-qualφ∏φ ity Biochemical reagents to choose fro≠¥∑m.

Equipment

Under the premise of developing a series o₹✘≥f diagnostic reagents with core tech✘&♥nology, our company independently develβ♦♠ops and manufactures correspondin≠αg instruments and equipment $ σ>to assist clinical judgment.